Clinical Trial Update: Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 safety and efficacy study of IVB102 for X-linked retinoschisis is registered and currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eye Diseases
• Retinal Degeneration
• Retinal Disease
• X-linked Retinoschisis

Drugs mentioned

• IVB102 Injection

Snippet

Sponsor: InnoVec Biotherapeutics Inc. | Conditions: Retinoschisis, Retinal Disease | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING